Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1578507505
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1520 San Pablo St, Suite 3000
Los Angeles, CA, 90033
Phone (323) 442-5710
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
1,232 services
Medicare patients, 2024
240
Average age 76
Drug cost, 2024
$553K
1,865 prescriptions
Company payments, 2025
$46K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark F Lew was code 99214 (office e&m - established), 315 times for 164 patients. In total Mark F Lew billed 1,232 services in 17 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 315 | 164 | $70.31 | $22K |
| 95874 Musculoskeletal | Facility | 113 | 37 | $14.18 | $1,602 |
| 64616 Musculoskeletal | Facility | 100 | 33 | $77.21 | $7,721 |
| 99214 Office E&M - Established | Office | 84 | 55 | $77.80 | $6,536 |
| 99215 Office E&M - Established | Facility | 63 | 46 | $117.71 | $7,416 |
| 64612 Musculoskeletal | Facility | 56 | 19 | $137.80 | $7,717 |
| 99213 Office E&M - Established | Facility | 16 | 11 | $52.49 | $840 |
| 99205 Office E&M - New | Facility | 16 | 16 | $130.39 | $2,086 |
| 99215 Office E&M - Established | Office | 12 | 11 | $123.21 | $1,479 |
By year: 2022 $78K for 1,793 services; 2023 $49K for 1,216 services; 2024 $64K for 1,232 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark F Lew prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 448 prescriptions and refills. In total Mark F Lew wrote 1,865 Medicare prescriptions that cost $553K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 448 | 938 | 109 | $21K |
| Rasagiline Mesylate Generic | 235 | 434 | 49 | $64K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 189 | 364 | 41 | $8,919 |
| Clonazepam Generic | 128 | 145 | 21 | $789 |
| Rytary Carbidopa/Levodopa | 109 | 152 | 22 | $152K |
| Amantadine Amantadine Hcl | 91 | 190 | 24 | $5,923 |
| Mirtazapine Generic | 58 | 106 | 16 | $1,019 |
| Trazodone Hcl Generic | 57 | 97 | 17 | $287 |
| Entacapone Generic | 52 | 116 | 11 | $12K |
| Quetiapine Fumarate Generic | 43 | 79 | Under 11 | $888 |
| Ropinirole Er Ropinirole Hcl | 36 | 50 | Under 11 | $3,360 |
| Sertraline Hcl Generic | 29 | 75 | Under 11 | $2,055 |
| Baclofen Generic | 29 | 37 | Under 11 | $366 |
| Lorazepam Generic | 27 | 27 | Under 11 | $172 |
| Gocovri Amantadine Hcl | 26 | 26 | Under 11 | $86K |
Brand drugs: 282 claims; generic drugs: 1,583 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark F Lew $46K ($46K in general payments such as food, travel and fees) from 5 companies. The largest payer was MDD US Operations, LLC with $44K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.